iTonic Holdings Ltd (ITOC) stock
Close on Nov 11, 2026Market cap $36.66MP/E –Yield –
iTonic Holdings Ltd grew revenue 16.7% to $523.03K over fiscal 2025. Free cash flow was -$3.24M. At the latest close the market valued the company at $36.66M.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- $36.66M
- P/E ratio
- –
- Price to sales
- 70.09
- Price to book
- 1.55
- Dividend yield
- –
- Free cash flow yield
- -8.83%
Fundamentals
- Revenue
- $523.03K
- Net income
- -$5.10M
- EPS, diluted
- -$0.32
- Free cash flow
- -$3.24M
Trading
- Previous close
- $2.01
- Open
- $2.03
- Day's range
- $1.80 – $2.35
- Volume
- 133,885
- Average volume (20 days)
- 25,472
- Beta (5 years)
- 1.38
- 52-week range
- $1.63 – $18.40
- RSI (14 days)
- 35.8
- Volatility (1 year)
- 169.7%
- Relative volume
- 3.17×
- WACC
- 11.8%
Market cap history
Month-end market cap since 2024, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | ITOC | S&P 500 | Difference | ITOC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -47.1% | -2.4% | −44.7 pts | ||
| 3 months | -53.7% | -1.2% | −52.5 pts | ||
| Year to date | -68.1% | +12.3% | −80.4 pts | ||
| 1 year | -77.6% | +12.4% | −90.1 pts |
Five years at a glance
Fiscal years 2021 to 2025, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases iTonic filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About iTonic
Electromedical & Electrotherapeutic Apparatus
iTonic Holdings Ltd is a healthcare and medical technology company that develops and supplies radiation therapy products through its operating subsidiary. The company specializes in brachytherapy solutions, primarily focusing on its proprietary Feitian Treatment Planning Software, a system that designs customized treatment plans for radioactive particle implantation across multiple malignant solid tumor types. In addition to software, it provides medical auxiliary supplies utilized in brachytherapy procedures, including implant guns, body supporting stents, three-dimensional printing molds, and patient immobilization equipment.
Company profile, executives and historyiTonic stock: common questions
What is iTonic's stock price?
ITOC closed at $2.15 on Nov 11, 2026, up 6.97% on the day. Over the past 52 weeks it traded between $1.63 and $18.40.
What is iTonic's market cap?
iTonic was worth $36.66M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is ITOC's P/E ratio?
iTonic lost money over fiscal 2025 (diluted EPS -$0.32), so it has no meaningful P/E ratio.
How much revenue does iTonic make?
iTonic reported revenue of $523.03K for fiscal 2025, up 16.7% from a year earlier.
Does iTonic pay a dividend?
No. iTonic has not paid a cash dividend over the last twelve months.
How has ITOC stock performed over the past year?
Including dividends, ITOC returned -77.6% over the past year, against +12.4% for the S&P 500.
How many ITOC shares are sold short?
0M shares were sold short at the latest FINRA report, 0.04% of the float, or 1.0 days of average trading volume.
Who are iTonic's competitors?
Companies most similar to iTonic by business, industry and size include GTHP, POSC, NXL, HRGN, ADMT.
See a number that looks wrong?